CVS logo

CVS Health Corporation (CVS) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

CVS, 73.02$ (piyasa değeri $92.90B) fiyatla Healthcare işi olan CVS Health Corporation'i temsil ediyor. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 47/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 8 Şub 2026
47/100 AI Puanı Hedef $96.50 (+32.2%) PD $92.90B Hacim 5.54M

CVS Health Corporation (CVS) Sağlık ve Boru Hattı Genel Bakışı

CEOJ. David Joyner
Çalışanlar219000
MerkezWoonsocket, RI, US
Halka Arz Yılı1996
SektörHealthcare

CVS Health Corporation delivers integrated healthcare solutions through its pharmacy services, retail locations, and health insurance plans, leveraging its extensive network and innovative services to improve patient outcomes and drive shareholder value with a 3.40% dividend yield and a beta of 0.50.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 8 Şub 2026

Yatırım Tezi

CVS Health presents a notable research candidate due to its integrated healthcare model and strategic positioning within the growing healthcare market. The company's diverse revenue streams, spanning pharmacy services, retail healthcare, and health insurance, provide resilience and growth potential. CVS's MinuteClinics and Health Care Benefits segment offer significant expansion opportunities, driven by increasing demand for accessible and affordable healthcare. With a dividend yield of 3.40%, CVS offers an attractive income stream for investors. Key value drivers include the company's ability to manage healthcare costs, improve patient outcomes, and expand its digital healthcare offerings. While the company's profit margin is currently at 0.1%, strategic initiatives aimed at improving operational efficiency and expanding higher-margin services are expected to drive profitability improvements in the coming years. The company's low beta of 0.50 suggests lower volatility compared to the broader market.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Operates approximately 9,900 retail locations and 1,200 MinuteClinic locations as of December 31, 2021, providing extensive access to healthcare services.
  • Offers a dividend yield of 3.40%, providing an attractive income stream for investors.
  • The company has a beta of 0.50, indicating lower volatility compared to the broader market.
  • Serves a diverse range of clients, including employer groups, individuals, and government entities, through its Health Care Benefits segment.
  • Provides pharmacy benefit management (PBM) solutions, including formulary management and specialty pharmacy services, through its Pharmacy Services segment.

Rakipler & Benzerleri

Güçlü Yönler

  • Large and established network of retail pharmacies and MinuteClinics.
  • Integrated healthcare model with pharmacy services, retail healthcare, and health insurance.
  • Strong brand recognition and customer loyalty.
  • Expertise in pharmacy benefit management (PBM).

Zayıflıklar

  • Low profit margin of 0.1%.
  • Exposure to regulatory changes and healthcare policy risks.
  • Dependence on prescription drug sales.
  • Competition from other healthcare providers and retailers.

Katalizörler

  • Ongoing: Expansion of MinuteClinic services and digital health initiatives to drive revenue growth and improve patient outcomes.
  • Ongoing: Growth in the pharmacy services segment and specialty pharmacy market, driven by increasing demand for cost-effective prescription drug management.
  • Upcoming: Potential strategic partnerships and acquisitions to expand capabilities and market reach in the healthcare industry.
  • Ongoing: Increasing demand for accessible and affordable healthcare, creating opportunities for CVS to expand its services and customer base.

Riskler

  • Potential: Increasing competition from online pharmacies and retailers could erode market share and pressure prices.
  • Ongoing: Rising healthcare costs and pressure to reduce prices could negatively impact profitability.
  • Ongoing: Regulatory changes and healthcare policy risks could impact CVS's business model and operations.
  • Potential: Economic downturn and reduced consumer spending could negatively impact sales and profitability.
  • Potential: Litigation and legal challenges related to pharmacy practices and healthcare services.

Büyüme Fırsatları

  • Expansion of MinuteClinic Services: CVS has the opportunity to expand its MinuteClinic footprint and service offerings. The market for convenient, walk-in medical care is growing, driven by increasing demand for accessible and affordable healthcare. By expanding its MinuteClinic network and offering a wider range of services, CVS can attract new customers and increase revenue. This expansion aligns with the trend towards value-based care and the growing demand for convenient healthcare access. The market size for walk-in clinics is projected to reach $40 billion by 2028, presenting a significant growth opportunity for CVS.
  • Growth in Pharmacy Services Segment: The Pharmacy Services segment offers significant growth potential through expanding its PBM solutions and specialty pharmacy services. The market for PBM services is growing, driven by increasing demand for cost-effective prescription drug management. By expanding its PBM offerings and leveraging its scale, CVS can attract new clients and increase revenue. The specialty pharmacy market is also growing rapidly, driven by the increasing prevalence of chronic diseases and the development of new specialty drugs. CVS can capitalize on this trend by expanding its specialty pharmacy services and offerings.
  • Digital Health Initiatives: CVS can leverage digital health technologies to enhance its services and improve patient outcomes. The market for digital health solutions is growing rapidly, driven by increasing adoption of telehealth, mobile health apps, and wearable devices. By investing in digital health initiatives, CVS can improve patient engagement, enhance access to care, and reduce healthcare costs. This includes expanding its telehealth services, developing mobile health apps, and integrating wearable devices into its care management programs. The digital health market is projected to reach $660 billion by 2027, presenting a significant growth opportunity for CVS.
  • Expansion of Health Care Benefits Segment: The Health Care Benefits segment offers growth opportunities through expanding its health insurance products and services. The market for health insurance is growing, driven by increasing healthcare costs and the aging population. By expanding its health insurance offerings and leveraging its integrated model, CVS can attract new members and increase revenue. This includes offering a wider range of health insurance plans, expanding its Medicare and Medicaid offerings, and partnering with healthcare providers to improve care coordination. The health insurance market is projected to reach $1.5 trillion by 2028, presenting a significant growth opportunity for CVS.
  • Strategic Partnerships and Acquisitions: CVS can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This includes partnering with healthcare providers, technology companies, and other healthcare organizations to enhance its services and improve patient outcomes. CVS can also pursue acquisitions to expand its geographic reach, enter new markets, and acquire new technologies. Strategic partnerships and acquisitions can help CVS accelerate its growth and strengthen its competitive position in the healthcare industry.

Fırsatlar

  • Expansion of MinuteClinic services and digital health initiatives.
  • Growth in the pharmacy services segment and specialty pharmacy market.
  • Strategic partnerships and acquisitions to expand capabilities and market reach.
  • Increasing demand for accessible and affordable healthcare.

Tehditler

  • Increasing competition from online pharmacies and retailers.
  • Rising healthcare costs and pressure to reduce prices.
  • Regulatory changes and healthcare policy risks.
  • Economic downturn and reduced consumer spending.

Rekabet Avantajları

  • Scale and scope: CVS has a vast network of retail pharmacies and MinuteClinics, providing convenient access to healthcare services for millions of customers.
  • Integrated model: CVS's integrated model, combining pharmacy services, retail healthcare, and health insurance, allows it to manage costs, improve patient outcomes, and enhance access to healthcare services.
  • Brand recognition: CVS is a well-known and trusted brand in the healthcare industry.
  • PBM expertise: CVS has extensive expertise in pharmacy benefit management (PBM), providing cost-effective prescription drug management solutions for employers and health plans.

CVS Hakkında

Founded in 1963 and headquartered in Woonsocket, Rhode Island, CVS Health Corporation has evolved from a chain of health and beauty stores into a diversified healthcare giant. Originally known as CVS Caremark Corporation, the company rebranded to CVS Health Corporation in 2014 to reflect its broader commitment to health and well-being. CVS operates through three primary segments: Health Care Benefits, Pharmacy Services, and Retail/LTC. The Health Care Benefits segment offers a range of health insurance products, serving employer groups, individuals, and government entities. The Pharmacy Services segment provides pharmacy benefit management (PBM) solutions, including formulary management and specialty pharmacy services. The Retail/LTC segment operates approximately 9,900 retail locations and 1,200 MinuteClinic locations as of December 31, 2021, offering prescription drugs, over-the-counter medications, and consumer health products. CVS's integrated model allows it to manage costs, improve patient outcomes, and enhance access to healthcare services. The company's strategic focus on expanding its healthcare services and digital capabilities positions it for continued growth in the evolving healthcare landscape.

Ne Yaparlar

  • Provides pharmacy benefit management (PBM) services to employers and health plans.
  • Operates retail pharmacies offering prescription and over-the-counter medications.
  • Offers health insurance products and services through its Health Care Benefits segment.
  • Provides healthcare services through MinuteClinic walk-in medical clinics.
  • Sells consumer health and beauty products in its retail stores.
  • Distributes prescription drugs to care facilities and other care settings.
  • Offers specialty pharmacy services for patients with chronic conditions.
  • Provides infusion and enteral nutrition services.

İş Modeli

  • Generates revenue from pharmacy benefit management (PBM) fees.
  • Generates revenue from the sale of prescription and over-the-counter medications in its retail pharmacies.
  • Generates revenue from premiums and fees from its health insurance products.
  • Generates revenue from providing healthcare services in its MinuteClinics.
  • Generates revenue from the sale of consumer health and beauty products.

Sektör Bağlamı

CVS Health operates in the dynamic and rapidly evolving healthcare industry. The market is characterized by increasing demand for accessible, affordable, and integrated healthcare solutions. Key trends include the shift towards value-based care, the growing adoption of digital health technologies, and the increasing prevalence of chronic diseases. CVS competes with other major players in the healthcare industry, including health insurance companies like ELV and CI, pharmaceutical companies like BMY and GSK, and other retail pharmacy chains. The company's integrated model, combining pharmacy services, retail healthcare, and health insurance, differentiates it from its competitors and positions it to capitalize on the growing demand for comprehensive healthcare solutions.

Kilit Müşteriler

  • Employers who use CVS's PBM services to manage prescription drug benefits for their employees.
  • Individuals who purchase prescription and over-the-counter medications at CVS pharmacies.
  • Individuals and families who enroll in CVS's health insurance plans.
  • Patients who receive healthcare services at CVS MinuteClinics.
  • Care facilities and other care settings that purchase prescription drugs from CVS.
AI Güveni: 72% Güncellendi: 8 Şub 2026

Finansallar

Grafik & Bilgi

CVS Health Corporation (CVS) hisse senedi fiyatı: $73.02 (+0.00, +0.00%)

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

CVS için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

Konsensüs hedefi: $96.50

MoonshotScore

47/100

Bu puan ne anlama geliyor?

MoonshotScore, CVS'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

En Son CVS Health Corporation Analizi

CVS Hakkında Sıkça Sorulan Sorular

CVS için değerlendirilmesi gereken temel faktörler nelerdir?

CVS Health Corporation (CVS) şu anda yapay zeka skoru 47/100, düşük puanı gösteriyor. Hisse 53.3x F/K oranıyla işlem görüyor, S&P 500 ortalamasının (~20-25x) üzerinde, yüksek büyüme beklentilerine işaret ediyor. Analist hedefi $96.50 ($73.02'dan +32%). Temel güçlü yan: Large and established network of retail pharmacies and MinuteClinics.. İzlenmesi gereken birincil risk: Potential: Increasing competition from online pharmacies and retailers could erode market share and pressure prices.. Bu bir finansal tavsiye değildir.

CVS MoonshotScore'u nedir?

CVS şu anda MoonshotScore'da 47/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

CVS verileri ne sıklıkla güncellenir?

CVS fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler CVS hakkında ne diyor?

Analistler, CVS için $96.50 konsensüs fiyat hedefi belirledi, bu mevcut fiyattan ($73.02) yukarı yönlü %32 potansiyeli temsil ediyor. Kapsam, al, tut ve sat derecelendirmelerini, kazanç tahminlerini ve son yükseltmeleri veya düşürmeleri içerir. Tüm ayrıntılar için bu sayfadaki Analist Konsensüsü bölümüne bakın.

CVS'a yatırım yapmanın riskleri nelerdir?

CVS için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Increasing competition from online pharmacies and retailers could erode market share and pressure prices.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. 53.3x F/K oranıyla, büyüme beklentileri karşılanamazsa değerleme riski taşıyor. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

CVS'ın P/E oranı nedir?

CVS Health Corporation (CVS)'nın son P/E oranı 53.3, ki bu da piyasa ortalamasının üzerinde, bu da yüksek büyüme beklentilerini gösterebilir. P/E (fiyat-kazanç) oranı, hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Bağlam için bunu sektördeki emsallerle ve S&P 500 ortalamasıyla (~20-25x) karşılaştırın. Yüksek bir P/E beklenen gelecekteki büyümeyi yansıtabilirken, düşük bir P/E değer düşüklüğünü veya azalan kazançları gösterebilir. Bu bir finansal tavsiye değildir.

CVS aşırı değerli mi, yoksa düşük değerli mi?

CVS Health Corporation (CVS)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. P/E oranı 53.3. Analist hedefi $96.50 (mevcut fiyattan +32%), analistlerin yukarı yönlü potansiyel gördüğünü gösteriyor. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

CVS'ın temettü verimi nedir?

CVS Health Corporation (CVS) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Fiyat itibarıyla Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Stock data pending update.
  • Financial metrics based on the most recent available data.
Veri Kaynakları

Popüler Hisseler